Authors
Nataliya Zelisko, Roman Lesyk
Published in
Expert opinion on drug discovery. Pages 1-19. Nov 01, 2026. Epub Nov 01, 2026.
Abstract
Synthetic chemistry is a fundamental driver of medicinal chemistry, yet increasing molecular complexity conflicts with the need for rapid, diverse, scalable, and sustainable synthesis. Despite the rapid expansion of synthetic methodologies, pharmaceutical manufacturing remains dominated by a narrow repertoire of established reactions. This disparity highlights a central paradox: reaction innovation has advanced far more rapidly than its practical adoption.
A literature search was conducted using Web of Science, Scopus, and PubMed, covering publications from 2000 to 2026. This Perspective examines established and emerging synthetic strategies shaping modern drug discovery, including large-scale synthesis, late-stage functionalization, click chemistry, combinatorial and structure-based approaches, continuous-flow processing, and photochemistry and green chemistry. Literature trends and representative examples are used to assess the transition of emerging methodologies from academic innovation to pharmaceutical application, with particular emphasis on their ability to expand chemical space, accelerate compound generation, and improve synthetic efficiency.
The central challenge is no longer the invention of new reactions, but their effective translation into accessible chemical space. Future progress will depend on integrating synthetic innovation with computational and combinatorial approaches, automation, flow technologies, and sustainable chemistry. Such integration could shift medicinal chemistry from optimizing increasingly complex molecules toward expanding the diversity of compounds that may be efficiently synthesized, evaluated, and developed as drugs.
PMID:
42968521
Bibliographic data and abstract were imported from PubMed on 02 Nov 2026.
Read full publication at:
Please sign in
to see all details.
Advertisement
Stats
- Recommendations n/a n/a positive of 0 vote(s)
- Views 3
- Comments 0